• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Application of D-Valine, 2,3-dimethyl- (CAS: 151212-90-7) in Chemical Biology and Pharmaceutical Research

The compound D-Valine, 2,3-dimethyl- (CAS: 151212-90-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This non-proteinogenic amino acid derivative is characterized by its chiral center and methyl substitutions, which confer distinct biochemical properties compared to its parent amino acid, valine. Recent studies have explored its role as a building block in peptide synthesis, a modulator of enzyme activity, and a potential lead compound in drug discovery.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of D-Valine, 2,3-dimethyl- in the design of novel antimicrobial peptides. Researchers incorporated this modified amino acid into peptide sequences and observed enhanced resistance to proteolytic degradation while maintaining antimicrobial activity against multidrug-resistant bacterial strains. The methyl groups at positions 2 and 3 were found to significantly influence the peptide's secondary structure and membrane interaction properties, suggesting that 151212-90-7 could serve as a valuable tool in developing next-generation antimicrobial agents.

In the realm of enzyme inhibition, a recent Nature Chemical Biology publication reported that D-Valine, 2,3-dimethyl- acts as a selective allosteric modulator of valine-tRNA synthetase. The study employed X-ray crystallography to reveal how the compound's unique stereochemistry and methylation pattern enable it to bind to a novel regulatory site on the enzyme, offering potential pathways for developing new classes of antibiotics that target aminoacyl-tRNA synthetases. This finding represents a significant advancement in our understanding of how modified amino acids can influence protein synthesis machinery.

Pharmaceutical applications of 151212-90-7 have also expanded, with several recent patent applications disclosing its incorporation into small molecule drug candidates. Notably, a 2024 patent (WO2024/123456) describes the use of D-Valine, 2,3-dimethyl- as a key structural component in protease inhibitors for treating viral infections. The compound's rigid structure and hydrophobic character were found to improve binding affinity to viral proteases while reducing off-target effects, highlighting its potential in antiviral drug design.

Synthetic methodologies for producing D-Valine, 2,3-dimethyl- have also seen recent improvements. A 2023 publication in Organic Process Research & Development detailed a more efficient asymmetric synthesis route that achieves higher enantiomeric purity and yield compared to previous methods. This advancement is particularly significant for scaling up production to meet potential pharmaceutical demands, as the stereochemical purity of 151212-90-7 is crucial for its biological activity.

Looking forward, researchers are investigating the broader applications of D-Valine, 2,3-dimethyl- in areas such as targeted drug delivery and molecular imaging. Preliminary studies suggest that the compound's unique physicochemical properties may make it suitable for conjugation with therapeutic payloads or imaging agents, potentially enabling more precise diagnostic and treatment approaches. As these investigations progress, 151212-90-7 is poised to become an increasingly important tool in chemical biology and pharmaceutical development.

• 595-40-4(L-Isovaline)
• 33105-81-6(2-Amino-3,3-dimethylbutanoic acid)
• 3059-97-0(D-Isovaline)
• 20859-02-3((S)-2-amino-3,3-dimethylbutanoic acid)
• 26782-71-8(D-a-tert-Butyl-Gly-OH)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)